Astrup A, Breum L, Toubro S, et al. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double-blind trial.
Int J Obes Relat Metab Disord.
1992;16:269-277.
Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Int J Obes Relat Metab Disord.
2000;24:1573-1578.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Int J Obes Relat Metab Disord.
1994;18:99-103.
Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Int J Obes Relat Metab Disord.
2001;25:316-324.
Norregaard J, Jorgensen S, Mikkelsen KL, et al. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Clin Pharmacol Ther.
1996;60:679-686.
Astrup A, Breum L, Toubro S, et al. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double-blind trial.
Int J Obes Relat Metab Disord.
1992;16:269-277.
Molnar D, Torok K, Erhardt E, et al. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Int J Obes Relat Metab Disord.
2000;24:1573-1578.
Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Int J Obes Relat Metab Disord.
1994;18:99-103.
Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Int J Obes Relat Metab Disord.
2001;25:316-324.
Norregaard J, Jorgensen S, Mikkelsen KL, et al. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Clin Pharmacol Ther.
1996;60:679-686.
Astrup A, Breum L, Toubro S. Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Obes Res.
1995;3:537S-540S.
MedscapeWire. No association between reported adverse events and ephedra when consumed as directed. Available at:
http://www.medscape.com/MedscapeWire/2000/08...medwire.0816.Nol. Accessed August 16, 2000.
Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements.
Am J Health Syst Pharm. 2000;57:963-969.
MedscapeWire. No association between reported adverse events and ephedra when consumed as directed. Available at:
http://www.medscape.com/MedscapeWire/2000/08...medwire.0816.Nol. Accessed August 16, 2000.
Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
N Engl J Med. 2000;343:1833-1838.
Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements.
Am J Health Syst Pharm. 2000;57:963-969.
Physicians' Desk Reference For Herbal Medicines. Montvale, NJ: Medical Economics Co; 1998:827.
Samenuk D, Link M, Homoud M K, et al. Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine.
Mayo Clin Proc. 2002;77:12-16.
Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
Int J Obes Relat Metab Disord. 2002;26:593-604.
Meston CM, Heiman JR. Ephedrine-activated physiological sexual arousal in women.
Arch Gen Psychiatry. 1998;55:652-656.
Nishiguchi M, Kinoshita H, Higasa K, et al. The false positive reaction of the Triage panel drug-of-abuse by herbal drugs ma-huang (Ephedra sinica Ephedraceae).
Nippon Hoigaku Zasshi. 2001;55:331-338.
Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use.
Neurology. 1993;43:1313-1316.
Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink.
J Clin Psychopharmacol.
1997;17:437-439.
Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang.
Am J Gastroenterol. 2001;96:1654-1655.
Nadir A, Agrawal S, King PD, et al. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.
Am J Gastroenterol. 1996;91:1436-1438.
Zaacks SM, Klein L, Tan CD, et al. Hypersensitivity myocarditis associated with ephedra use
J Toxicol Clin Toxicol. 1999;37:485-489.
Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: ephedrine nephrolithiasis.
Am J Kidney Dis. 1998;32:153-159.
Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation.
Toxicol Sci. 2000;56:424-430.
Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
JAMA. 2003;289:1537-1545.
Bent S, Tiedt TN, Odden MC, et al. The relative safety of ephedra compared with other herbal products.
Ann Intern Med. 2003;138:468-471.
Coffey CS, Steiner D, Baker BA, et al. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Int J Obes Relat Metab Disord. 2004 Aug 31. [Epub ahead of print]
Meston CM. A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual Dysfunction.
J Sex Marital Ther. 2004;30:57-68.
Levisky JA, Karch SB, Bowerman DL, et al. False-positive RIA for methamphetamine following ingestion of an ephedra-derived herbal product.
J Anal Toxicol. 2003;27(2):123-124.
Walton R, Manos GH. Psychosis related to ephedra-containing herbal supplement use.
South Med J. 2003;96:718-720.
Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation.
Eur J Gastroenterol Hepatol. 2005;17:581-584.
FDA statement on Tenth Circuit's ruling to uphold FDA decision banning dietary supplements containing ephedrine alkaloids. Food and Drug Administration website. Available at:
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01434.html. Accessed: October 30, 2007.
Sales of supplements containing ephedrine alkaloids (ephedra) prohibited. Food and Drug Administration website. Available at:
http://www.fda.gov/oc/initiatives/ephedra/febru...2004/default.htm. Accessed: October 30, 2007.
Chen WL, Tsai TH, Yang CC, Kuo TB.
Effects of ephedra on autonomic nervous modulation in healthy young adults.
J Ethnopharmacol.
2010;130(3):563-568.
Hallas J, Bjerrum L, Støvring H, Andersen M.
Use of a prescribed ephedrine/caffeine combination and the risk of serious cardiovascular events: a registry-based case-crossover study.
Am J Epidemiol.
2008;168(8):966-973.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.